Proximagen Articles

Flurry of M&A activity in Europe, with takeovers for NeuroNova and Proximagen

13 June 2012

UK's Proximagen boosted by US lorcaserin news with respect to its own obesity drug candidate

14 May 2012

Proximagen boasts strong cash balance, updates on R&D

5 March 2012

Lundbeck partners with Proximagen, buying around a 9%equity stake in the firm

30 September 2011

Proximagen acquires two CNS drug development programs from GlaxoSmithKline

23 December 2010

Upsher-Smith signs agreement to sublicense tonabersat from Proximagen to expand its CNS portfolio

13 April 2010

Showing 1-6 of 6 articles

Go to beginningPrevious
  • 1
NextGo to end